Furthermore, brodalumab, which is a human monoclonal antibody human anti-IL17RA, a pan inhibitor of IL-17A, IL-17F, and IL-25 is currently used in the treatment of psoriasis where shows a complete clearance of moderate-to-severe psoriasis (97). The gene discussed is IL17RA; the disease is psoriasis.